These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 11283668)

  • 61. Xyloketal B attenuates atherosclerotic plaque formation and endothelial dysfunction in apolipoprotein e deficient mice.
    Zhao LY; Li J; Yuan F; Li M; Zhang Q; Huang YY; Pang JY; Zhang B; Sun FY; Sun HS; Li Q; Cao L; Xie Y; Lin YC; Liu J; Tan HM; Wang GL
    Mar Drugs; 2015 Apr; 13(4):2306-26. PubMed ID: 25874925
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Absence of p-selectin, but not intercellular adhesion molecule-1, attenuates neointimal growth after arterial injury in apolipoprotein e-deficient mice.
    Manka D; Collins RG; Ley K; Beaudet AL; Sarembock IJ
    Circulation; 2001 Feb; 103(7):1000-5. PubMed ID: 11181476
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Time course of increased cellular proliferation in collateral arteries after administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency.
    Takeshita S; Rossow ST; Kearney M; Zheng LP; Bauters C; Bunting S; Ferrara N; Symes JF; Isner JM
    Am J Pathol; 1995 Dec; 147(6):1649-60. PubMed ID: 7495290
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells.
    Wojta J; Kaun C; Breuss JM; Koshelnick Y; Beckmann R; Hattey E; Mildner M; Weninger W; Nakamura T; Tschachler E; Binder BR
    Lab Invest; 1999 Apr; 79(4):427-38. PubMed ID: 10211995
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Expression of vascular endothelial growth factor in human monocyte/macrophages stimulated with lipopolysaccharide.
    Itaya H; Imaizumi T; Yoshida H; Koyama M; Suzuki S; Satoh K
    Thromb Haemost; 2001 Jan; 85(1):171-6. PubMed ID: 11204570
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1.
    Barleon B; Sozzani S; Zhou D; Weich HA; Mantovani A; Marmé D
    Blood; 1996 Apr; 87(8):3336-43. PubMed ID: 8605350
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo.
    Schuch G; Machluf M; Bartsch G; Nomi M; Richard H; Atala A; Soker S
    Blood; 2002 Dec; 100(13):4622-8. PubMed ID: 12453880
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia.
    Namiki M; Kawashima S; Yamashita T; Ozaki M; Hirase T; Ishida T; Inoue N; Hirata K; Matsukawa A; Morishita R; Kaneda Y; Yokoyama M
    Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):115-20. PubMed ID: 11788470
    [TBL] [Abstract][Full Text] [Related]  

  • 69. HMG-CoA reductase inhibitor, fluvastatin, has cholesterol-lowering independent "direct" effects on atherosclerotic vessels in high cholesterol diet-fed rabbits.
    Mitani H; Egashira K; Kimura M
    Pharmacol Res; 2003 Nov; 48(5):417-27. PubMed ID: 12967585
    [TBL] [Abstract][Full Text] [Related]  

  • 70. VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism.
    Pipp F; Heil M; Issbrücker K; Ziegelhoeffer T; Martin S; van den Heuvel J; Weich H; Fernandez B; Golomb G; Carmeliet P; Schaper W; Clauss M
    Circ Res; 2003 Mar; 92(4):378-85. PubMed ID: 12600898
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Statins have biphasic effects on angiogenesis.
    Weis M; Heeschen C; Glassford AJ; Cooke JP
    Circulation; 2002 Feb; 105(6):739-45. PubMed ID: 11839631
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo.
    Gabrilovich D; Ishida T; Oyama T; Ran S; Kravtsov V; Nadaf S; Carbone DP
    Blood; 1998 Dec; 92(11):4150-66. PubMed ID: 9834220
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E.
    Wang YX; Martin-McNulty B; Huw LY; da Cunha V; Post J; Hinchman J; Vergona R; Sullivan ME; Dole W; Kauser K
    Atherosclerosis; 2002 May; 162(1):23-31. PubMed ID: 11947894
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies.
    Bellamy WT; Richter L; Frutiger Y; Grogan TM
    Cancer Res; 1999 Feb; 59(3):728-33. PubMed ID: 9973224
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cells.
    Spiekermann K; Faber F; Voswinckel R; Hiddemann W
    Exp Hematol; 2002 Jul; 30(7):767-73. PubMed ID: 12135675
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Enhancement of prostate cancer xenograft growth with whole-body radiation and vascular endothelial growth factor.
    Gridley DS; Andres ML; Slater JM
    Anticancer Res; 1997; 17(2A):923-8. PubMed ID: 9137429
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Plaque-associated endothelial dysfunction in apolipoprotein E-deficient mice on a regular diet. Effect of human apolipoprotein AI.
    Crauwels HM; Van Hove CE; Holvoet P; Herman AG; Bult H
    Cardiovasc Res; 2003 Jul; 59(1):189-99. PubMed ID: 12829190
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Vascular endothelial growth factor-induced cardiovascular malformations in embryo development].
    Feucht M; Christ B; Wilting J
    Ann Anat; 1998 Oct; 180(5):387-9. PubMed ID: 9795687
    [No Abstract]   [Full Text] [Related]  

  • 79. Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model.
    Montrucchio G; Lupia E; Battaglia E; Del Sorbo L; Boccellino M; Biancone L; Emanuelli G; Camussi G
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):80-8. PubMed ID: 10634803
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Broad-spectrum CC-chemokine blockade by gene transfer inhibits macrophage recruitment and atherosclerotic plaque formation in apolipoprotein E-knockout mice.
    Bursill CA; Choudhury RP; Ali Z; Greaves DR; Channon KM
    Circulation; 2004 Oct; 110(16):2460-6. PubMed ID: 15477414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.